NCT00887627View on ClinicalTrials.gov

Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Kidney DiseasesHyponatremia
Interventions
DRUG

conivaptan hydrochloride

intravenous

Trial Locations (1)

92801

Anaheim

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY

NCT00887627 - Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function | Biotech Hunter | Biotech Hunter